Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...
On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...
Feeling drained and low on focus? The truth is, most vitamins for energy only help if you’re deficient in something essential ...
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...
Merck and Eisai Announce WELIREG® Plus LENVIMA® Met Primary Endpoint of PFS in Certain Previously Treated Patients With ...
2-Year U.S. Treasury Note Continuous Contract $104.348 0.000 0.00% 5-Year U.S. Treasury Note Continuous Contract $109.680 0.000 0.00% 10-Year U.S. Treasury Note Continuous Contract $113.484 0.016 0.01 ...
Hyperthyroidism (overactive thyroid) doesn’t usually cause weight gain, though it may cause other weight changes. Sometimes, treatment for hyperthyroidism can lead to weight gain. Hyperthyroidism ...
A recent systematic review identified only 47 cases of hypothyroid cardiac tamponade worldwide between 2000 and 2023, with notably no cases reported from Sub-Saharan Africa, highlighting a significant ...
We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated. We appreciate your ...
When the Federal Reserve hiked interest rates 11 times last year in a bid to control rampant economic inflation, many Top 400 Contractors said they felt those policy changes in the form of project ...
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...